Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Receptor-mediated Endocytosis

Receptor-mediated Endocytosis

Receptor-mediated Endocytosis

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...

Receptor-Mediated Endocytosis

Receptor-Mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...

The Early Endosome: Endocytosis of Transferrin

The Early Endosome: Endocytosis of Transferrin

Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...

The Extrinsic Apoptotic Pathway

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Suppressing protein Z-dependent inhibition of factor Xa improves coagulation in hemophilia A.

Journal of thrombosis and haemostasis : JTH·2018

Same author

Re-evaluation of mouse tissue factor pathway inhibitor and comparison of mouse and human tissue factor pathway inhibitor physiology.

Journal of thrombosis and haemostasis : JTH·2018

Same author

Evidence of clinically significant extravascular stores of factor IX.

Journal of thrombosis and haemostasis : JTH·2013

Same author

Protein Z, protein Z-dependent protease inhibitor (serpinA10), and the acute-phase response.

Journal of thrombosis and haemostasis : JTH·2012

Same author

The C-terminus of tissue factor pathway inhibitor α is required for its interaction with factors V and Va.

Journal of thrombosis and haemostasis : JTH·2012

Same author

Tissue factor pathway inhibitor and the revised hypothesis of blood coagulation.

Trends in cardiovascular medicine·2011

Search research articles

Related Experiment Video

Updated: Jun 5, 2026

Extracellular Vesicle Tissue Factor Activity Assay

Extracellular Vesicle Tissue Factor Activity Assay

Published on: December 29, 2023

Tissue factor pathway inhibitor endocytosis.

A L Schwartz¹, G J Broze

¹Departments of Pediatrics and Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

Trends in Cardiovascular Medicine

|January 18, 2011

Summary

This summary is machine-generated.

Tissue factor pathway inhibitor (TFPI) regulates blood clotting by inhibiting key factors. It is cleared from circulation primarily by liver endocytosis, mediated by specific cell surface proteins.

More Related Videos

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Published on: May 24, 2024

Related Experiment Videos

Last Updated: Jun 5, 2026

Extracellular Vesicle Tissue Factor Activity Assay

Extracellular Vesicle Tissue Factor Activity Assay

Published on: December 29, 2023

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Published on: May 24, 2024

Area of Science:

Biochemistry
Hematology
Cell Biology

Background:

Tissue factor pathway inhibitor (TFPI) is a critical regulator of the extrinsic coagulation cascade.
TFPI inhibits coagulation initiation by targeting factor Xa and the factor VIIa/tissue factor complex.
TFPI exists in plasma, bound to lipoproteins, and in a releasable pool on endothelial cells.

Purpose of the Study:

To elucidate the physiological role and clearance mechanisms of TFPI.
To identify the primary mediators of TFPI clearance from circulation.

Main Methods:

Review of existing literature on TFPI function and pharmacokinetics.
Analysis of TFPI binding interactions and cellular uptake pathways.

Main Results:

TFPI primarily circulates bound to lipoproteins, with a significant pool releasable from endothelial surfaces.
Heparin sulfate proteoglycans and the low-density lipoprotein receptor-related protein (LRP) are key mediators of TFPI clearance.
Receptor-mediated endocytosis into the liver is the main route for TFPI elimination.

Conclusions:

TFPI plays a vital role in controlling coagulation initiation.
Liver uptake via LRP and proteoglycans is the predominant mechanism for TFPI clearance.
Understanding TFPI clearance is crucial for its therapeutic applications in hemostasis.